Literature DB >> 14766304

Cloning, high level expression, purification, and crystallization of the full length Clostridium botulinum neurotoxin type E light chain.

Rakhi Agarwal1, Subramaniam Eswaramoorthy, Desigan Kumaran, John J Dunn, Subramanyam Swaminathan.   

Abstract

The catalytic activity of the highly potent botulinum neurotoxins are confined to their N-terminal light chains ( approximately 50kDa). A full-length light chain for the type E neurotoxin with a C-terminal 6x His-tag, BoNT/E-LC, has been cloned in a pET-9c vector and over-expressed in BL21 (DE3) cells. BoNT/E-LC was purified to homogeneity by affinity chromatography on Ni-NTA agarose followed by exclusion chromatography using a Superdex-75 sizing column. The purified protein has very good solubility and can be stored stably at -20 degrees C; however, it seems to undergo auto-proteolysis when stored at temperature #10878;4-10 degrees C. BoNT/E-LC is active on its natural substrate, the synaptosomal associated 25kDa protein, SNAP-25, indicating that it retains a native-like conformation and therefore can be considered as a useful tool in studying the structure/function of the catalytic light chain. Recombinant BoNT/E-LC has been crystallized under five different conditions and at various pHs. Crystals diffract to better than 2.1A.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14766304     DOI: 10.1016/j.pep.2003.10.017

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  8 in total

1.  Vaccination of rabbits with an alkylated toxoid rapidly elicits potent neutralizing antibodies against botulinum neurotoxin serotype B.

Authors:  Daniel M Held; Amy C Shurtleff; Scott Fields; Christopher Green; Julie Fong; Russell G A Jones; Dorothea Sesardic; Roland Buelow; Rae Lyn Burke
Journal:  Clin Vaccine Immunol       Date:  2010-04-21

2.  SNAP-25 substrate peptide (residues 180-183) binds to but bypasses cleavage by catalytically active Clostridium botulinum neurotoxin E.

Authors:  Rakhi Agarwal; Subramanyam Swaminathan
Journal:  J Biol Chem       Date:  2008-07-25       Impact factor: 5.157

3.  High level expression, purification and immunogenicity analysis of a protective recombinant protein against botulinum neurotoxin type E.

Authors:  Ebrahim Valipour; Mir-Latif Moosavi; Jafar Amani; Shahram Nazarian
Journal:  World J Microbiol Biotechnol       Date:  2014-01-29       Impact factor: 3.312

4.  Mode of VAMP substrate recognition and inhibition of Clostridium botulinum neurotoxin F.

Authors:  Rakhi Agarwal; James J Schmidt; Robert G Stafford; Subramanyam Swaminathan
Journal:  Nat Struct Mol Biol       Date:  2009-06-21       Impact factor: 15.369

5.  Lucanthone and its derivative hycanthone inhibit apurinic endonuclease-1 (APE1) by direct protein binding.

Authors:  Mamta D Naidu; Rakhi Agarwal; Louis A Pena; Luis Cunha; Mihaly Mezei; Min Shen; David M Wilson; Yuan Liu; Zina Sanchez; Pankaj Chaudhary; Samuel H Wilson; Michael J Waring
Journal:  PLoS One       Date:  2011-09-15       Impact factor: 3.240

6.  Development of immunodetection system for botulinum neurotoxin serotype E.

Authors:  R Sarita; Sarkaraisamy Ponmariappan; Arti Sharma; Dev Vrat Kamboj; A K Jain
Journal:  Indian J Med Res       Date:  2018-06       Impact factor: 2.375

Review 7.  Evolutionary Features in the Structure and Function of Bacterial Toxins.

Authors:  Raj Kumar; Thomas M Feltrup; Roshan V Kukreja; Kruti B Patel; Shuowei Cai; Bal Ram Singh
Journal:  Toxins (Basel)       Date:  2019-01-03       Impact factor: 4.546

8.  Characterization of immune response induced against catalytic domain of botulinum neurotoxin type E.

Authors:  Priyanka Sonkar; Vinita Chauhan; Ritika Chauhan; Nandita Saxena; Ram Kumar Dhaked
Journal:  Sci Rep       Date:  2020-08-18       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.